Logo-apb
Adv Pharm Bull. 2025;15(4): 735-749. doi: 10.34172/apb.025.45842
PMID: 41835051        PMCID: PMC12980211

Review Article

Hydrogel Micro/Nanostructures for the Delivery of Oncolytic Viruses: Overcoming Limitations and Improving Efficacy

Chou-Yi Hsu 1 ORCID, Saade Abdalkareem Jasim 2 * ORCID, Jasur Alimdjanovich Rizaev 3, Tina Saeed Basunduwah 4 ORCID, Vikrant Abbot 5, Mamata Chahar 6, Mohammed Asiri 7, Abbas Fadhel Ali 8, Alexey Yumashev 9 ORCID, Ahmed Hussein Zwamel 10,11,12

Cited by CrossRef:


1- Arjeini Y, Khalili Dermani S, Sadeh S, Abdolalipour E, Saberpour M, Zargaran H, Mohebbi S, Ghaemi A. Oncolytic viruses in brain cancer therapy: advances, challenges, and clinical trial outcomes. Immunotherapy. 2026;18(3):249 [Crossref]